Credo Diagnostics Biomedical Pte. Ltd. / Singapore
台灣醫療科技展展位:N/A
今日的醫生,每天都面臨著診斷的微妙挑戰,但他們可用的工具遠非完美。醫生經常不得不在性能和便利之間進行權衡。
自 2011 年以來,Credo Diagnostics Biomedical 專注於革命性診斷技術的研究和開發,開發、製造和商業化一個準確、快速且價格合理的醫療點分子診斷平台用於人類感染性疾病: VitaPCRTM。
我們意識到有必要以更低的成本簡化流程並加快診斷周轉時間,同時確保最佳準確性,我們為人類健康和動物護理領域的診斷提供解決方案。
診斷公司對醫生和患者負有道德責任和義務,以提供更好的工具,我們設想有效的快速 POC 分子診斷將重新定義人類和獸醫臨床管理的醫療保健。
 
成立時間2011
資本額USD 13,638,794
員工數227
產品/服務類別
醫事機構 數位醫療 智慧健康 醫資軟體 醫療器材 檢測診斷 醫用設備 防疫科技
採購與合作需求項目
N/A
供應與銷售項目
We are looking for reputable distributors worldwide to help us penetrate the local market and deliver outstanding customer experience
We provide sample-to-answer solutions for fast molecular diagnosis at an affordable cost for the detection of infectious disease
Healthcare providers and local distributors are welcomed to contact us for pricing and product information.
We are seeking for the collaboration opportunities of Joint Clinical Research
特色產品
VitaPCR™ is an innovative rapid molecular diagnostic platform based on the well-established Polymerase Chain Reaction (PCR) technology which allows significantly faster testing than any other laboratory molecular method. It is also more accurate than conventional rapid testing. VitaPCR™ enables the detection of infectious diseases in less than 20 minutes from sample to results, at the Point-of-Care. A real Point-of-Care solution, VitaPCR™ empowers practitioners with the correct information at the right time to make the right decision and provide the right course of treatment to the patients. Combining a simplified 1 minutes hands-on time procedure to ensure seamless integration into practitioners’ workflow, the VitaPCR™ has a compact and reliable design that doesn’t require extra equipment like refrigeration and a proprietary PCR technology that allows a faster and more accurate diagnostics; VitaPCR™ offers a far superior level of performance than existing Point-of-Care diagnostic solutions, at a price point making it widely affordable for the masses.
應用範疇
The VitaPCR™ Instrument can be deployed anywhere in hospitals, clinical labs, healthcare centers, clinics, airports, train stations, etc.
特色優勢
Minimal training required for operation / 1 min hands-on time for experiment setup / Sample to result in less than 20 mins / Intuitive result interpretation with Ct value & fluorescence Curve / Can be deployed anywhere / No additional equipment is needed
產品/服務類別
醫事機構 智慧健康 醫資軟體 醫療器材 檢測診斷 醫用設備 預防醫學 防疫科技
說明文件
FlYER VitaPCR.pdf
VitaPCR™ SARS-CoV-2 Gen 2 Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (rRT-PCR) amplification technology for the qualitative detection of SARS-CoV-2. The product contains primers, fluorophore-labeled probes and control material used in real-time RT-PCR for the in vitro qualitative detection of specific SARS-CoV-2 RNA in respiratory specimens.
應用範疇
For use with the VitaPCR™ Instrument.
For nasopharyngeal (NP) or oropharyngeal (OP) swab specimens.
For in vitro diagnostic use only.
特色優勢
VitaPCR™ SARS-CoV-2 Gen 2 Assay is designed to detect two targets located on regions of the nucleocapsid (N) gene of SARS-CoV-2. The assay also includes an artificial single-strand RNA as an internal control (IC) to monitor the whole RT-PCR process.
Detection of target sequences is achieved by real-time measuring cleaved fluorophore-labeled detection probes following sequence amplification by specific primer pairs. The turnaround time for the sample analysis is approximately 20 minutes, and the hands-on time is only 1 minute. Furthermore, the reagent can be stored at room temperature for ease of use.
產品/服務類別
醫事機構 智慧健康 醫資軟體 醫療器材 檢測診斷 醫用設備 預防醫學 防疫科技
VitaPCR™ Flu A&B Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (rRT-PCR) amplification technology for the qualitative detection and differentiation of influenza A and influenza B. The product contains primers, fluorophore-labeled probes and control material used in real-time RT-PCR for the in vitro qualitative detection of specific influenza A and influenza B RNA in direct nasal (NS) swabs and nasopharyngeal (NP) swabs from patients.
應用範疇
For use with the VitaPCR™ Instrument.
For nasal (NS) or nasopharyngeal (NP) specimens.
For in vitro diagnostic use only.

特色優勢
VitaPCR™ Flu A&B Assay is designed to detect two targets, Influenza A and Influenza B. The assay also includes an artificial single-strand RNA as an internal control (IC) to monitor the whole RT-PCR process. Detection of target sequences is achieved by real-time measuring cleaved fluorophore-labeled detection probes following sequence amplification by specific primer pairs. The turnaround time for the sample analysis is approximately 20 minutes, and the hands-on time is only 1 minute. Furthermore, the reagent can be stored at room temperature for ease of use.

VitaPCR™ Flu A&B Assay is a rapid, immediate molecular diagnostic test for the qualitative detection and differentiation of influenza A and influenza B viral RNAs from nasal or nasopharyngeal swabs of patients in 20 minutes.
產品/服務類別
醫事機構 智慧健康 醫資軟體 醫療器材 檢測診斷 醫用設備 預防醫學 防疫科技
VitaPCR™ Influenza/SARS-CoV-2 (Flu/SC2) Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (rRT-PCR) amplification technology for the qualitative detection and differentiation of influenza A, influenza B, and SARS-CoV-2. The product contains primers, fluorophore-labeled probes, and control material used in real-time RT-PCR for the in vitro qualitative detection of specific influenza A, influenza B, and SARS-CoV-2 RNA in nasopharyngeal (NP) swabs from patients.
應用範疇
For use with the VitaPCR™ Instrument.
For nasopharyngeal (NP) swab specimens.
For in vitro diagnostic use only.
特色優勢
VitaPCR™ Influenza/SARS-CoV-2 (Flu/SC2) Assay is designed to detect three targets simultaneously, including Influenza A, Influenza B, and SARS-CoV-2. The assay also includes an artificial single-strand RNA as an internal control (IC) to monitor the whole RT-PCR process. Detection of target sequences is achieved by real-time measuring cleaved fluorophore-labeled detection probes following sequence amplification by specific primer pairs. The turnaround time for the sample analysis is approximately 20 minutes, and the hands-on time is only 1 minute. Furthermore, the reagent can be stored at room temperature for ease of use.
產品/服務類別
醫事機構 智慧健康 醫資軟體 醫療器材 檢測診斷 醫用設備 預防醫學 防疫科技
VitaPCR™ Flu & RSV Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (rRT-PCR) amplification technology for the qualitative detection and differentiation of influenza A, influenza B, and RSV. The product contains primers, fluorophore-labeled probes, and control material used in real-time RT-PCR for the in vitro qualitative detection of specific influenza A, influenza B, and RSV RNA in direct nasal (NS) swabs and nasopharyngeal (NP) swabs from patients.
應用範疇
For use with the VitaPCR™ Instrument.
For nasal (NS) or nasopharyngeal (NP) swab specimens.
For in vitro diagnostic use only.
特色優勢
VitaPCR™ Flu & RSV Assay is designed to detect three targets simultaneously, including Influenza A, Influenza B, and RSV. The assay also includes an artificial single-strand RNA as an internal control (IC) to monitor the whole RT-PCR process. Detection of target sequences is achieved by real-time measuring cleaved fluorophore-labeled detection probes following sequence amplification by specific primer pairs. The turnaround time for the sample analysis is approximately 20 minutes, and the hands-on time is only 1 minute. Furthermore, the reagent can be stored at room temperature for ease of use.
產品/服務類別
醫事機構 智慧健康 醫資軟體 醫療器材 檢測診斷 醫用設備 預防醫學 防疫科技
The VitaPCR™Strep A Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (PCR) amplification technology for the qualitative detection of

Streptococcus pyogenes (Group A ß -hemolytic Streptococcus, Strep A) in oropharyngeal (OP) throat swab specimens from patients with signs and symptoms of pharyngitis.

應用範疇
For use with the VitaPCR™ Instrument.
For oropharyngeal (OP)or throat swab specimens
For in vitro diagnostic use only.
特色優勢
The VitaPCR™Strep A Assay can be used as an aid in the diagnosis of Group A streptococcal pharyngitis .The results should not be used as the sole basis for diagnosis ,treatment or other patient management decisions.
The VitaPCR™Strep A Assay is intended for use by all healthcare professionals.
產品/服務類別
醫事機構 智慧健康 醫資軟體 醫療器材 檢測診斷 醫用設備 預防醫學 防疫科技
最新商機情報
你可能有興趣的產品服務
你可能有興趣的機構/企業
© Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy
聯絡我們
Loading...